J&J sues to block Concerta generic; Celebrex may help prevent skin cancer;

@FiercePharma: Law and order on the social media frontier. Report | Follow @FiercePharma

> Two Johnson & Johnson units sued Teva Pharmaceutical Industries and Impax Laboratories in federal court in Delaware to halt the sale of generic Concerta, the ADHD drug. News

> The prescription painkiller Celebrex might help prevent non-melanoma skin cancers, a small study suggests. Report

> Shanghai Pharmaceuticals shares surged by the daily limit in Shanghai trading after it announced plans to acquire China Health System to expand its distribution network. Article

> Pristine Pharma is relocating its manufacturing to Massena, New York, and is expected to create up to 100 jobs there, according to CEO Venkat E. Kakani. Report

Special Report: Big Pharma behaving badly: A timeline of settlements. Report 

> The U.K., in a decision to underscore its "moral opposition to the death penalty," plans to limit the export of a drug used widely in U.S. executions. Story

> A Jefferies International analyst cut his rating on Shire, citing slowing earnings momentum in the near term and competitive pressure on the market for ADHD drugs. Item

> Eli Lilly is razing an 80,000-square-foot warehouse adjacent to its Indianapolis headquarters complex; the warehouse will be replaced by a parking lot serving the corporate campus. News

Special Report: Four Star Trek medical technologies we use today. Report 

> Bimeda, a maker of pharmaceutical products for animals, agreed to pay a $7,000 fine and spend an additional $58,800 on environmental upgrades after the Minnesota Pollution Control Agency identified hazardous waste violations at its facility. Article

Biotech News

 @FierceBiotech: GSK's Witty calls for an R&D renaissance. Story | Follow @FierceBiotech

 @JohnCFierce: Basilea awarded $130M from J&J after the pharma company dumped their antibiotic pact--after the trials were messed up. Report | Follow @JohnCFierce

> Keryx claims a front-line victory with PhIII Zerenex data. Article

> PwC: FDA gets better grade for guidance, flunks review. Report

> FDA cites vandetanib toxicity ahead of AZ panel review. News

Biotech Research News

> BioTime, CIRM reach deal on embryonic stem cell lines. Story

> Why are Queenslanders getting skin cancer? News

> USB drive could connect microfluidic device to big world. Item

> Scientists reverse old-age symptoms in mice. Story

> Researchers discover way to delay prostate cancer progression. Article

Manufacturing News

> Gilead opens process kimono on AIDS drug. Item

> French Mediator crisis shows need for global regs. Article

> Medicago, BU design tobacco vax factories. Report

> UK tax break to yield big GSK manufacturing investment. Item

> Aveva plant restart rekindles BioDelivery, ProStrakan. Story 

And Finally... Narcissistic personality disorder, characterized by an inflated sense of self-importance and the need for constant attention, has been eliminated from the forthcoming edition of the DSM-V, a manual psychiatrists use to diagnose mental illness. Report